Transcription of RXR-α mRNA before therapy and after relapse of disease. Real-time PCR of RXR-α was performed from patient PBMCs collected at day 0 before therapy and day 180 after initiating therapy. No change in the relative mean fold change in expression over time was found when comparing to day 0 of therapy.